Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of prophylactic effect of amiodarone versus amiodarone plus vitamin C on post-CABG atrial fibrillation
IRCT20141209020258N66Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of amiodarone and ascorbic acid in Atrial fibrillation (AFib) and coronary arteriosclerosis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Incidence of postoperative atrial fibrillation. Started Nov 2017; status: completed.
02
Drugs
amiodaroneascorbic acid
03
Conditions
Atrial fibrillation (AFib)coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20141209020258N66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N66.